Herpesvirus Antiviral Resistance
Database
Language
English
French
Spanish
German
CNR Website
Home
Login
Data
All data
Antivirals
Bibliography
Therapeutic targets
Tools
Search
Submit mutations
Request expertise
Genotyping tool
Contact
Notice
Last update : Wed 22 May 2024
TOP
Antiviral therapy
Short name: Antivir Ther
References:
-
A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet. ( 2006).
-
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009).
-
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. ( 2009).
-
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007).
-
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008).
Filter:
Mutant
Gene
Virus
Reference
Mutations:
P10L
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
L11P
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
P12L
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A58T
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
D81N
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A83V
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A84P
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A84V
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
K90R
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
H97R
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
L133I
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A134T
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
E229D
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
N289D
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
D294N
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
D294G
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
H297Y
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
D298G
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
N300G
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
P307L
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
V310A
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
H313Y
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
D351N
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
S363W
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
I367V
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
G421E
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
R465C
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
T519A
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A520V
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
R531Q
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
H557Q
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A558V
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
A565T
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
P571T
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
H606Y
UL27
Human betaherpesvirus 5
Conserved domains and structure prediction of human cytomegalovirus UL27 protein. ( 2009)
N495K
UL54
Human betaherpesvirus 5
A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet. ( 2006)
N495K
UL54
Human betaherpesvirus 5
A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet. ( 2006)
N495K
UL54
Human betaherpesvirus 5
A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet. ( 2006)
E2K
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
V12L
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
D242G
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A327V
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
E393K
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A425V
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
G436E
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
M442T
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A444G
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
S445N
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
N446del
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
449-451del
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
T452I
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
S454N
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
G460V
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A464T
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
V471A
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
V476A
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
E485G
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
R507C
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
Q577R
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
D586N
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A648R
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A648S
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
L658F
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
S749N
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
V778A
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
V793A
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
P800L
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
P803A
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
A812E
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
L831M
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
G840A
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
S848N
UL56
Human betaherpesvirus 5
Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity. ( 2008)
T37A
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
L89P
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
D94N
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
K95E
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
H216R
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
G239C
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
Q244H
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
Q249H
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
K253Q
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
K253T
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
E254A
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
R258P
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
A283P
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
N294D
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
S345A
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
T448I
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
C511F
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
I531V
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
L548V
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
G635S
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
A663V
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
D665E
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
A668P
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
F671S
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
R672K
UL89
Human betaherpesvirus 5
New functional domains of human cytomegalovirus pUL89 predicted by sequence analysis and three-dimensional modelling of the catalytic site DEXDc. ( 2007)
E596del
UL97
Human betaherpesvirus 5
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. ( 2009)
K599E
UL97
Human betaherpesvirus 5
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. ( 2009)